Publication Name	World Journal of Diabetes
Manuscript ID	62278
Country	Chile

Received	2021-01-04 13:44
Peer-Review Started	2021-01-04 13:45
To Make the First Decision
Return for Revision	2021-01-25 01:13
Revised	2021-01-29 19:05
Second Decision	2021-04-07 12:34
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-04-07 20:52
Articles in Press	2021-04-07 20:52
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2021-04-23 01:54
Publish the Manuscript Online	2021-05-06 11:18

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, Research & Experimental
Manuscript Type	Minireviews
Article Title	Advanced-glycation end-products axis: A contributor to the risk of severe illness from COVID-19 in diabetes patients
Manuscript Source	Invited Manuscript
All Author List	Armando Rojas, Cristian Lindner, Ileana Gonzàlez and Miguel Angel Morales
Funding Agency and Grant Number
Corresponding Author	Armando Rojas, PhD, Full Professor, Biomedical Research Labs, Medicine Faculty, Catholic University of Maule, 3605 San Miguel Avenue, Talca 3605, Chile. arojasr@ucm.cl
Key Words	COVID-19; Diabetes mellitus; Advanced glycation; Alarmins; Advanced-glycation end-products axis; Inflammation
Core Tip	Compelling evidences support that diabetes mellitus increases the risk of coronavirus disease 2019 complications, as well as the overall syndrome coronavirus 2 case-fatality. Different reports have suggested the putative involvement of several molecular mechanisms underlying this increased risk. We herein discuss the contribution of the activation of the receptor for advanced-glycation end-products axis to the higher risk for severe illness reported in diabetes patients with coronavirus disease 2019.
Publish Date	2021-05-06 11:18
Citation	Rojas A, Lindner C, Gonzàlez I, Morales MA. Advanced-glycation end-products axis: A contributor to the risk of severe illness from COVID-19 in diabetes patients. World J Diabetes 2021; 12(5): 590-602
URL	https://www.wjgnet.com/1948-9358/full/v12/i5/590.htm
DOI	https://dx.doi.org/10.4239/wjd.v12.i5.590

Full Article (PDF)	WJD-12-590.pdf
Full Article (Word)	WJD-12-590.docx
Manuscript File	62278_Auto_Edited_LM.docx
Answering Reviewers	62278-Answering reviewers.pdf
Audio Core Tip	62278-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	62278-Conflict-of-interest statement.pdf
Copyright License Agreement	62278-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	62278-Language certificate.pdf
Peer-review Report	62278-Peer-review(s).pdf
Scientific Misconduct Check	62278-Scientific misconduct check.pdf
Scientific Editor Work List	62278-Scientific editor work list.pdf